^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

miR‑625‑3p overexpression

i
Other names: MiR625, MicroRNA 625, Hsa-MiR-625-3p, Hsa-MiR-625-5p, MIMAT0004808, MIMAT0003294, Hsa-MiR-625, MI0003639, MiRN625, RF00027, MiR625
Entrez ID:
Related biomarkers:
3years
MicroRNA-625-3p improved proliferation and involved chemotherapy resistance via targeting PTEN in high grade ovarian serous carcinoma. (PubMed, J Ovarian Res)
miR-625-3p promotes HGSOC growth, involves chemotherapy resistance and might serve as a potential biomarker to predict chemotherapy response and prognosis in HGSOC.
Journal • IO biomarker
|
PTEN (Phosphatase and tensin homolog) • BCL2 (B-cell CLL/lymphoma 2) • BAX (BCL2-associated X protein) • MIR625 (MicroRNA 625)
|
BCL2 expression • PTEN expression • miR‑625‑3p overexpression
|
cisplatin
over4years
MicroRNA-625-3p promotes cell migration of oral squamous cell carcinoma by regulating SCAI expression. (PubMed, Eur Rev Med Pharmacol Sci)
MicroRNA-625-3p is highly expressed in OSCC, which promotes cell migration of OSCC by regulating SCAI expression.
Journal
|
CDH1 (Cadherin 1) • MIR625 (MicroRNA 625)
|
CDH1 expression • miR‑625‑3p overexpression